Media Resources

RxAir360 in the News

Resources for journalists, editors, and media professionals covering healthcare innovation, hyperbaric medicine, and medical device technology.

Latest News

Media & Blog

Stay updated with the latest interviews, news, and insights from RxAir360

The Morning Experience with Marquis Lupton
Listen Now
Featured Interview March 2026

Founder Diallo Watts Appears on "The Mornin' Experience"

Join Founder & CEO Diallo M. Watts, Sr. and Chief Strategy Officer Tony Brown as they discuss: "Hyperbaric oxygen therapy shouldn't be limited to 1,300 facilities in America. Why closing this access gap matters — especially for the communities that need it most."

WLIT 106 FM • "The Mornin' Experience" with Marquis Lupton

Never Miss an Update

Subscribe to our media list to get the latest news, interview links, and announcements delivered directly to your inbox.

Media Assets

Product Images

High-resolution images of the RxAir360 chamber and system components for media use.

RxAir360 Chamber

RxAir360 Monoplace Chamber System

FDA Pending • Community-Ready Design

RxAir360 Chamber
View
RxAir360 Chamber Testing
View
RxAir360 Chamber Detail
View
RxAir360 Chamber Side View
View

Logo & Brand Assets

Request logos and brand assets for media use.

RxAir360 Logo

Primary Logo

RxAir360

Wordmark

All Assets

Company Leadership

Founder Biography

Diallo M. Watts, Sr.

Diallo M. Watts, Sr.

Founder & Chief Executive Officer

Watch Origin Story on YouTube

Use this version everywhere a short bio is needed.

Diallo M. Watts, Sr. is the Founder and CEO of RxAir360 Inc., a medical technology company focused on expanding access to hyperbaric oxygen therapy by bringing HBOT into physician practice environments. A trained electrical engineer with more than 25 years of experience in engineering, entrepreneurship, and executive leadership, he leads the company's regulatory, engineering, and commercialization strategy. Under his leadership, RxAir360 has raised more than $3.65 million in early-stage funding and is advancing a patented hyperbaric oxygen therapy system designed for integration within physician offices.

Media Contact Email

[email protected]

Phone

(240) 640-4560

Media Appearances

March 2026: "The Mornin' Experience" - WLIT 106 FM (with Tony Brown, CSO)

Topic: Geographic Disparities in Access to Hyperbaric Oxygen Therapy

Education

B.S. Electrical Engineering, Morgan State University

Location

Bellaire, Texas (HQ)

Approved Company Description

For use in articles, press releases, and media coverage

Short Version (1 Sentence)

RxAir360 Inc. is a pre-revenue medical technology company developing hyperbaric oxygen therapy (HBOT) systems for physician offices, pending FDA 510(k) clearance.

Long Version (Paragraph)

RxAir360 Inc. is a Bellaire, Texas-based medical technology company developing innovative hyperbaric oxygen therapy (HBOT) systems designed specifically for physician offices. Unlike traditional hyperbaric chambers requiring large hospital spaces, the RxAir360 vertical monoplace system fits within a standard exam room, rides a standard elevator, and requires no facility renovation. The company has filed Form 211 for OTC market qualification and is advancing toward FDA 510(k) clearance. RxAir360 is backed by over 200 investors including physicians, self-directed IRA holders, and accredited individuals. The device is not yet cleared by the FDA and is not available for sale or clinical use.

Request Media Materials

For interview requests, image assets, executive bios, or additional background, please contact our media relations team.

Contact Media Relations

RxAir360 requests that any coverage of the company accurately reflect the pre-clearance status of the device and not represent it as commercially available. The RxAir360 chamber has not received FDA 510(k) clearance.

Company Facts

Company Name

RxAir360 Inc.

Founded

2022

Headquarters

Bellaire, Texas (Houston area)

Incorporation

Delaware Corporation

Stage

Pre-revenue medical technology company

Product

First vertically-oriented monoplace hyperbaric oxygen therapy chamber designed for physician offices

Regulatory Status

FDA 510(k) submission targeted for Q2 2026

Patent

Issued 2023; 18+ years of protection remaining

Market Maker

Glendale Securities, Inc.

Transfer Agent

Dynamic Stock Transfer, Inc.

Securities Counsel

The Parsons Law Firm

OTC Markets

Form 211 filed

Get in Touch

Media & Press Contact

For press inquiries, interview requests, or additional information

Antonio White

Press Contact - 480 Advisors

Press Guidelines

Response Time

We typically respond to media inquiries within 24-48 hours

Photography

High-resolution images available upon request

Interviews

CEO available for print, broadcast, and podcast interviews

Quotes & Attribution

Please contact us for approval before publishing quotes

Fact Verification

We're happy to verify facts and review technical details

Follow us for the latest updates